Peptide synthesis, special modified peptides Lymphocytic Choreomeningitis Virus (LCMV) Glycoprotein 33 (3341), LCMV GP1, gp33 (33-41)

Peptide synthesis, special modified peptides Lymphocytic Choreomeningitis Virus (LCMV) Glycoprotein 33 (3341), LCMV GP1, gp33 (33-41) Struktur
CAS-Nr.
Englisch Name:
Peptide synthesis, special modified peptides Lymphocytic Choreomeningitis Virus (LCMV) Glycoprotein 33 (3341), LCMV GP1, gp33 (33-41)
Synonyma:
CBNumber:
CB417583110
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

Peptide synthesis, special modified peptides Lymphocytic Choreomeningitis Virus (LCMV) Glycoprotein 33 (3341), LCMV GP1, gp33 (33-41) Eigenschaften

Sicherheit

Peptide synthesis, special modified peptides Lymphocytic Choreomeningitis Virus (LCMV) Glycoprotein 33 (3341), LCMV GP1, gp33 (33-41) Chemische Eigenschaften,Einsatz,Produktion Methoden

Peptide synthesis, special modified peptides Lymphocytic Choreomeningitis Virus (LCMV) Glycoprotein 33 (3341), LCMV GP1, gp33 (33-41) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Peptide synthesis, special modified peptides Lymphocytic Choreomeningitis Virus (LCMV) Glycoprotein 33 (3341), LCMV GP1, gp33 (33-41) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 1)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Beijing Zhongke Yaguang Biotechnology Co., Ltd. --
khc@scilight-peptide.com CHINA 76 58
Copyright 2019 © ChemicalBook. All rights reserved